.jpg.transform/400/image.jpg){kind=logo}
Delivering Solutions. Delivering Confidence.
CAPS is the nation's largest network of outsourcing admixture pharmacies. A pioneer in the outsourcing of compounded sterile preparations (CSP), founded in 1991, we deliver high-quality admixture services and solutions to hospitals and outpatient facilities across the nation. We offer 22 503A regional pharmacies registered to dispense your customized, patient-specific compounding needs and three 503B outsourcing facilities registered with the FDA to distribute non-patient-specific CSPs.
Learn about the latest intervention study published in Nutrition in Clinical Practice.
Watch the ASPEN 2021: CAPS® Central Stage Presentation
Presented by Michael D. Kraft, PharmD, BCNSP, FASPEN, Anne M. Tucker, PharmD, BCNSP and Sharon M. Durfee, RPh, BCNSP, FASPEN.
cGMP Level Release Testing (THR®)
Test Hold and Release (THR®) is CAPS' quality assurance program in response to the cGMP level standard created by the Drug Quality and Security Act (DQSA) for 503B facilities engaged in anticipatory compounding (compounding product batches without a prescription).
Welcome to the Oasis
Our extensive product catalog includes compounded sterile preparations including epinephrine and norepinephrine for therapeutic areas such as labor and delivery, operating room, general medicine, and critical care.
Latest News
-
CAPS to Roll Out Tromethamine at AmSECT
Read MoreHelping clinicians meet treatment needs, Central Admixture Pharmacy Services, Inc. (CAPS®) will introduce Tromethamine at this year’s American Society of ExtraCorporeal Technology conference.
